167 related articles for article (PubMed ID: 17691212)
41. Stability-indicating high performance thin layer chromatography determination of Paroxetine hydrochloride in bulk drug and pharmaceutical formulations.
Venkatachalam A; Chatterjee VS
Anal Chim Acta; 2007 Aug; 598(2):312-7. PubMed ID: 17719907
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of HPLC method for the determination of Cyclosporin A and its impurities in Neoral capsules and its generic versions.
Bonifacio FN; Giocanti M; Reynier JP; Lacarelle B; Nicolay A
J Pharm Biomed Anal; 2009 Feb; 49(2):540-6. PubMed ID: 19124213
[TBL] [Abstract][Full Text] [Related]
43. Separation and determination of synthetic impurities of difloxacin by reversed-phase high-performance liquid chromatography.
Rao RN; Nagaraju V
J Pharm Biomed Anal; 2004 Nov; 36(4):729-35. PubMed ID: 15533664
[TBL] [Abstract][Full Text] [Related]
44. Determination of 2,6-dimethylaniline and o-toluidine impurities in preparations for local anaesthesia by the HPLC method with amperometric detection.
Baczyński E; Piwońska A; Fijałek Z
Acta Pol Pharm; 2002; 59(5):333-9. PubMed ID: 12602793
[TBL] [Abstract][Full Text] [Related]
45. Chemometric quality control of chromatographic purity.
Laursen K; Frederiksen SS; Leuenhagen C; Bro R
J Chromatogr A; 2010 Oct; 1217(42):6503-10. PubMed ID: 20846660
[TBL] [Abstract][Full Text] [Related]
46. Spectrophotometric studies and application of imipramine-eriochrome cyanine R system for determination of imipramine in pharmaceuticals.
Starczewska B
J Pharm Biomed Anal; 2000 Aug; 23(2-3):383-6. PubMed ID: 10933530
[TBL] [Abstract][Full Text] [Related]
47. Impurity profiling of pharmaceuticals by thin-layer chromatography.
Ferenczi-Fodor K; Végh Z; Renger B
J Chromatogr A; 2011 May; 1218(19):2722-31. PubMed ID: 21255781
[TBL] [Abstract][Full Text] [Related]
48. Laser diffractometry and cascade impaction for nebulizer product characterization.
Mitchell JP; Tservistas M
Pharmeur Sci Notes; 2006 Dec; 2006(2):49-52. PubMed ID: 17691215
[TBL] [Abstract][Full Text] [Related]
49. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
Liu DQ; Sun M; Wu L
Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
[TBL] [Abstract][Full Text] [Related]
50. Updating the European Pharmacopoeia impurity profiling method for terazosin and suggesting alternative columns.
Enesei D; Kapui I; Fekete S; Kormány R
J Pharm Biomed Anal; 2020 Aug; 187():113371. PubMed ID: 32460215
[TBL] [Abstract][Full Text] [Related]
51. Sensitive assay for the tricyclic antidepressant Ro 11-2465 in biological fluids by high-performance liquid chromatography and fluorescence detection.
Haefelfinger P
J Chromatogr; 1982 Dec; 233():269-78. PubMed ID: 7161338
[TBL] [Abstract][Full Text] [Related]
52. Spectrophotometry assay of imipramine and desipramine using ammonium metavanadate and its application to pharmaceutical preparations.
Misiuk W
J Pharm Biomed Anal; 2000 Feb; 22(1):189-96. PubMed ID: 10727139
[TBL] [Abstract][Full Text] [Related]
53. The development of British pharmacopoeia monographs for idoxuridine and idoxuridine eye drops using high-pressure liquid chromatography for assay and for controlling related impurities.
Carr GP
J Chromatogr; 1978 Sep; 157():171-84. PubMed ID: 701441
[TBL] [Abstract][Full Text] [Related]
54. Polymer-coated fibrous extraction medium for sample preparation coupled to microcolumn liquid-phase separations.
Imaizumi M; Saito Y; Hayashida M; Takeichi T; Wada H; Jinno K
J Pharm Biomed Anal; 2003 Jan; 30(6):1801-8. PubMed ID: 12485721
[TBL] [Abstract][Full Text] [Related]
55. Accuracy profiles assessing the validity for routine use of high-performance thin-layer chromatographic assays for drug formulations.
Shewiyo DH; Kaale E; Risha PG; Dejaegher B; De Beer J; Smeyers-Verbeke J; Vander Heyden Y
J Chromatogr A; 2013 Jun; 1293():159-69. PubMed ID: 23639129
[TBL] [Abstract][Full Text] [Related]
56. Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.
Rousseau A; Marquet P; Comby F; Buxeraud J; Raby C; Lachâtre G
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):93-100. PubMed ID: 9200522
[TBL] [Abstract][Full Text] [Related]
57. How to evaluate the separation efficiency of CZE methods?
Büttner-Merz C; Holzgrabe U
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):81-8. PubMed ID: 21619858
[TBL] [Abstract][Full Text] [Related]
58. Impurities in drugs I: Imipramine, desipramine, and their formulations.
McErlane KM; Curran NM; Lovering EG
J Pharm Sci; 1977 Jul; 66(7):1015-8. PubMed ID: 886436
[TBL] [Abstract][Full Text] [Related]
59. Determination of the chemical structure of potential organic impurities occurring in the drug substance opipramol.
Luboch E; Wagner-Wysiecka E; Jamrógiewicz M; Szczygelska-Tao J; Magiełka S; Biernat JF
Pharmazie; 2010 Apr; 65(4):239-44. PubMed ID: 20432617
[TBL] [Abstract][Full Text] [Related]
60. Voltammetric determination of imipramine hydrochloride and amitriptyline hydrochloride using a polymer-modified carbon paste electrode.
Biryol I; Uslu B; Küçükyavuz Z
J Pharm Biomed Anal; 1996 Dec; 15(3):371-81. PubMed ID: 8951698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
